BioCentury
ARTICLE | Company News

Geron, Viragen option agreement

June 7, 2001 7:00 AM UTC

VRA received an option to non-exclusively license GERN's nuclear transfer patents for avian nuclear transfer. GERN will receive a cash payment and VRA equity in exchange for the option and, if exercis...